Related Experiment Videos
[Coronary endothelial dysfunction and graft atheromatosis following heart transplantation]
1Kardiologie, Universitätspital Zürich.
Insights
Graft atheromatosis, a key issue in heart transplant survival, involves myointimal proliferation and endothelial dysfunction. Early intervention and calcium-antagonist diltiazem may offer protective effects against this condition.
Area of Science:
- Cardiovascular Science
- Transplantation Immunology
Context:
- Graft atheromatosis significantly limits long-term survival following heart transplantation.
- Histological features include myointimal proliferation (circumscribed or diffuse) and endothelial dysfunction.
- Endothelial dysfunction, marked by impaired nitric oxide release, is an early indicator.
Purpose:
- To elucidate the pathophysiology of graft atheromatosis.
- To identify factors influencing its progression and functional consequences.
- To explore potential preventative or therapeutic strategies.
Summary:
- Graft atheromatosis progresses to coronary narrowing, impacting exercise-induced coronary flow reserve.
- Transplantation-related factors (rejection, infections) and cardiovascular risks (hypercholesterolemia, hypertension) exacerbate endothelial dysfunction.
- Risk factor modification and optimized immunosuppression may delay, but not prevent, the disease; diltiazem shows preliminary protective potential.
Impact:
- Understanding graft atheromatosis is crucial for improving long-term outcomes in heart transplant recipients.
- Identifying early functional disturbances (endothelial dysfunction) can guide clinical management.
- Further research into therapeutic agents like diltiazem may lead to novel treatment strategies.
Abstract:
Graft atheromatosis is the most important limiting factor on long-term survival after heart transplantation. Histologically it involves so-called myointimal proliferation occurring in either circumscribed or diffuse form. Endothelial dysfunction with impaired release of nitric oxide represents an early stage of graft atheromatosis. Progression of the disease typically leads to a diffuse narrowing of the coronary tree; however, focal stenoses may also occur. Endothelial dysfunction results in a decrease in physiological coronary flow reserve during exercise, whereas pharmacological flow reserve after papaverine or adenosine administration is maintained. This functional disturbance can be enhanced by transplantation-related (e.g., vascular graft rejections, cytomegalovirus infections, etc.) as well as by cardiovascular risk factors (e.g., hypercholesterolemia, hypertension). The occurrence of endothelial dysfunction and graft atheromatosis may be delayed, although probably not prevented, by elimination of risk factors and optimization of immunosuppressive treatment. Preliminary data suggest that long-term administration of the calcium-antagonist diltiazem may have a protective effect.